Stockhead on MSN
Biocurious: In a drug-development wasteland, Actinogen zeroes in on an effective Alzheimer’s disease treatment
While Alzheimer's drug developers have spent US$50 billion on suboptimal treatments, Actinogen strives for a breakthrough ...
News-Medical.Net on MSN
A common diabetes drug may prevent long COVID when taken early
By Dr. Priyom Bose, Ph.D. Large clinical trials and real-world data point to a familiar diabetes drug as a simple, safe way ...
Judge sharply questioned DOJ lawyers for a legal precedent for the Pentagon's attempt to punish Democratic Sen. Mark Kelly, a ...
Explore how boron compounds are revolutionising drug development with new stable boron-fluorine compounds for better ...
Atherosclerosis, the gradual buildup of cholesterol-rich plaque inside artery walls, is the driving force behind most heart ...
While the latest UK Government report into animal testing was keen to highlight a (very slight) decrease from 2.67 million ...
A Phase 2 trial is testing a weekly intranasal spray that primes early immune defenses to reduce respiratory virus illness.
Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, ...
From today, many patients in Campania suffering from myasthenia gravis - a rare and chronic autoimmune disease that weakens muscles, causing debilitating weakness - can administer their ...
Explore the Q4 2025 Alger Weatherbie Specialized Growth Fund performance. Read about the top contributors and detractors in ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and ...
Researchers found that cutting the vagus nerve in mice reduced dopamine activity and lessened the frequency of reward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results